Literature DB >> 12972963

Long-term results of preoperative radiotherapy for 113 cases of UT3 and UT4 rectal cancer: a need for long-term follow-up.

V Moutardier1, E Tardat, M Giovannini, B Lelong, J Guiramand, V Magnin, G Houvenaeghel, J R Delpero.   

Abstract

PURPOSE: Eighty percent of local recurrence after resection of rectal adenocarcinoma classically occurs within two years of surgery. Pretherapeutic staging is frequently limited to clinical examination, although the accuracy of endoanal ultrasonography has been demonstrated. The aim of this study was to report the long-term results of preoperative radiation therapy and resection of pretherapeutic endoanal ultrasonography-staged T3 and T4 rectal adenocarcinoma.
METHODS: This retrospective review analyzed a series of 113 patients who underwent radiation therapy followed by surgery. All patients underwent an endoanal ultrasonography. Median follow-up was 75 months.
RESULTS: Fifty-seven percent of patients were pT3 or T4. Thirty-six percent had involvement of lymph nodes. Five-year rates of survival, local recurrence-free survival, and disease-free survival were 79, 73, and 68 percent, respectively. Ten-year rates were 65, 63, and 62 percent, respectively. Median time to detection of local recurrence was 39 months. Eight of ten local recurrences occurred after two years of follow-up. Eight of ten patients with local recurrence had pretherapeutic endoanal ultrasonography-staged N+ tumors.
CONCLUSION: These results appear to justify a follow-up program for patients with pretherapeutic endoanal ultrasonography-staged N+ tumor. However, a minimum of seven years of follow-up is needed to obtain an accurate assessment of results.

Entities:  

Mesh:

Year:  2003        PMID: 12972963     DOI: 10.1007/s10350-004-6715-x

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy.

Authors:  Lukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Jacek Starzewski; Zbigniew Lorenc
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years.

Authors:  E Lezoche; M Guerrieri; A De Sanctis; R Campagnacci; M Baldarelli; G Lezoche; A M Paganini
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

3.  Practicability of quality goals for the treatment of rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Gunter Haroske; Erik Puffer; Thomas Jackisch; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2010-06-12       Impact factor: 2.571

Review 4.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

5.  Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.

Authors:  Robson Ferrigno; Paulo Eduardo Ribeiro dos Santos Novaes; Maria Letícia Gobo Silva; Ines Nobuko Nishimoto; Wilson Toshihiko Nakagawa; Benedito Mauro Rossi; Fábio de Oliveira Ferreira; Ademar Lopes
Journal:  Radiat Oncol       Date:  2006-03-28       Impact factor: 3.481

6.  Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy.

Authors:  Seung-Gu Yeo; Min-Jeong Kim; Dae Yong Kim; Hee Jin Chang; Min Ju Kim; Ji Yeon Baek; Sun Young Kim; Tae Hyun Kim; Ji Won Park; Jae Hwan Oh
Journal:  Radiat Oncol       Date:  2013-05-06       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.